• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞研究中的政策互操作性:揭开协调的神秘面纱。

Policy interoperability in stem cell research: demystifying harmonization.

作者信息

Isasi Rosario M

机构信息

CRDP, Université de Montréal, Montréal, Canada.

出版信息

Stem Cell Rev Rep. 2009 Jun;5(2):108-15. doi: 10.1007/s12015-009-9067-z. Epub 2009 Mar 31.

DOI:10.1007/s12015-009-9067-z
PMID:19521802
Abstract

Scientific developments in the field of stem cell research continue to emerge at incredible speed and so too has the contentious debate surrounding their broad implications. Though economic, socio-ethical and legal concerns remain, at both national and international forums; we are witnessing a departure from an "embryo-centric" approach, to one that is focused on the globalization of research and to the ensuing need for policy interoperability. The common response to the challenges associated with the meaning, scope, and ethical significance of variance in national policies, is a call for the creation of uniform legal and ethical standards. However, this call towards policy convergence on the fundamental ethical and governance principles underpinning policies choices has led to confusion and to the mystification of the notion of harmonization. In this article we aim demystify the notion of policy harmonization in the context of stem cell research. We will do so by surveying the diverse elements to be harmonized. We will then present the problems of policy interoperability in the context of the globalization of SC research, in order to propose that the goal of harmonization in this field lies in the identification of prospective strategies to foster seamless cross-jurisdictional collaboration. Finally, policy interoperability will be analyzed through the lens of a range of policy approaches addressing the cross-jurisdictional transfer of hESC lines with the aim of demonstrating that the apparent ethical-political-legal divide in some contexts largely vanishes once we grasp the notion of harmonization and identify points of convergence.

摘要

干细胞研究领域的科学发展仍在以惊人的速度不断涌现,围绕其广泛影响的争议性辩论也是如此。尽管在国家和国际论坛上,经济、社会伦理和法律问题依然存在;但我们正在见证一种从“以胚胎为中心”的方法转向专注于研究全球化以及随之而来的政策互操作性需求的转变。对于与国家政策差异的含义、范围和伦理意义相关的挑战,常见的应对措施是呼吁制定统一的法律和伦理标准。然而,这种要求在支撑政策选择的基本伦理和治理原则上实现政策趋同的呼声,却导致了混乱以及对协调概念的神秘化。在本文中,我们旨在揭开干细胞研究背景下政策协调概念的神秘面纱。我们将通过审视需要协调的各种要素来做到这一点。然后,我们将在干细胞研究全球化的背景下呈现政策互操作性问题,以便提出该领域协调的目标在于确定促进无缝跨辖区合作的前瞻性策略。最后,我们将通过一系列针对人类胚胎干细胞系跨辖区转移的政策方法来分析政策互操作性,目的是表明一旦我们理解协调概念并确定趋同点,某些情况下明显的伦理 - 政治 - 法律分歧在很大程度上就会消失。

相似文献

1
Policy interoperability in stem cell research: demystifying harmonization.干细胞研究中的政策互操作性:揭开协调的神秘面纱。
Stem Cell Rev Rep. 2009 Jun;5(2):108-15. doi: 10.1007/s12015-009-9067-z. Epub 2009 Mar 31.
2
[Ethical and biopolitical problems of the stem cell research].
Ther Umsch. 2006 Nov;63(11):711-5. doi: 10.1024/0040-5930.63.11.711.
3
Modelling human embryogenesis: embryo-like structures spark ethical and policy debate.模拟人类胚胎发育:类胚胎结构引发伦理和政策辩论。
Hum Reprod Update. 2020 Nov 1;26(6):779-798. doi: 10.1093/humupd/dmaa027.
4
Cloning and stem cells--handicapping the political and scientific debates.克隆与干细胞——阻碍政治和科学辩论
N Engl J Med. 2003 Jul 17;349(3):211-2. doi: 10.1056/NEJMp030088.
5
Resolving the "egg supply problem" in human embryonic stem cell derivation through technical means--a legal and ethical analysis.通过技术手段解决人类胚胎干细胞衍生中的“卵子供应问题”——法律与伦理分析
Med Law. 2008 Mar;27(1):167-78.
6
Harmonizing the international regulation of embryonic stem cell research: possibilities, promises and potential pitfalls.协调胚胎干细胞研究的国际监管:可能性、前景与潜在陷阱。
Med Law Int. 2005;7(2):113-48. doi: 10.1177/096853320500700202.
7
Modeling policy development: examining national governance of stem cell-based embryo models.模拟政策制定:审视基于干细胞的胚胎模型的国家治理
Regen Med. 2023 Feb;18(2):155-168. doi: 10.2217/rme-2022-0136. Epub 2023 Jan 5.
8
Ethical and regulatory aspects of embryonic stem cell research.胚胎干细胞研究的伦理和监管问题。
Expert Opin Biol Ther. 2005 Feb;5(2):153-62. doi: 10.1517/14712598.5.2.153.
9
Stem cells and ethics: current issues.干细胞与伦理学:当前的问题。
J Cardiovasc Transl Res. 2010 Apr;3(2):122-7. doi: 10.1007/s12265-009-9155-0. Epub 2009 Dec 1.
10
[An international comparative legal analysis of the regulation of research with human embryonic stem cells].[关于人类胚胎干细胞研究监管的国际比较法律分析]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):985-93. doi: 10.1007/s00103-008-0626-2.

引用本文的文献

1
Considerations for an integrated population health databank in Africa: lessons from global best practices.非洲综合人口健康数据库的考量:全球最佳实践的经验教训
Wellcome Open Res. 2021 Aug 23;6:214. doi: 10.12688/wellcomeopenres.17000.1. eCollection 2021.
2
Stem Cell-Based Therapies: What Interventional Radiologists Need to Know.基于干细胞的疗法:介入放射科医生需要了解的内容。
Semin Intervent Radiol. 2021 Nov 24;38(5):523-534. doi: 10.1055/s-0041-1736657. eCollection 2021 Dec.
3
Uncertainty and innovation: Understanding the role of cell-based manufacturing facilities in shaping regulatory and commercialization environments.

本文引用的文献

1
The changing landscape of European and international regulation on embryonic stem cell research.欧洲及国际层面胚胎干细胞研究监管的不断变化态势。
Stem Cell Res. 2009 Mar;2(2):101-7. doi: 10.1016/j.scr.2008.10.003. Epub 2008 Nov 17.
2
Monetary payments for the procurement of oocytes for stem cell research: In search of ethical and political consistency.为干细胞研究采购卵母细胞的金钱支付:寻求伦理与政治的一致性。
Stem Cell Res. 2007 Oct;1(1):37-44. doi: 10.1016/j.scr.2007.09.003. Epub 2007 Sep 18.
3
Importing human pluripotent stem cell lines derived at another institution: tailoring review to ethical concerns.
不确定性与创新:理解基于细胞的制造设施在塑造监管和商业化环境中的作用。
Appl Transl Genom. 2016 Nov 11;11:27-39. doi: 10.1016/j.atg.2016.11.001. eCollection 2016 Dec.
4
Research Translation and Emerging Health Technologies: Synthetic Biology and Beyond.研究转化与新兴健康技术:合成生物学及其他
Health Care Anal. 2018 Dec;26(4):310-325. doi: 10.1007/s10728-016-0334-2.
5
Ethical Issues for Clinical Studies That use Human Embryonic Stem Cells: The 2014 Revisions to the Japanese Guidelines.使用人类胚胎干细胞进行临床研究的伦理问题:日本指南的 2014 年修订版。
Stem Cell Rev Rep. 2015 Oct;11(5):676-80. doi: 10.1007/s12015-015-9607-7.
6
Policy recommendations for addressing privacy challenges associated with cell-based research and interventions.应对基于细胞的研究和干预措施相关隐私挑战的政策建议。
BMC Med Ethics. 2014 Feb 3;15:7. doi: 10.1186/1472-6939-15-7.
7
From banking to international governance: fostering innovation in stem cell research.从银行业到国际治理:促进干细胞研究的创新。
Stem Cells Int. 2011;2011:498132. doi: 10.4061/2011/498132. Epub 2011 Sep 5.
8
Stem cell banking: between traceability and identifiability.干细胞库:在可追溯性和可识别性之间。
Genome Med. 2010 Oct 5;2(10):73. doi: 10.1186/gm194.
9
Stem cell research in the Greater Middle East: the importance of establishing policy and ethics interoperability to foster international collaborations.大中东地区的干细胞研究:建立政策和伦理互操作性以促进国际合作的重要性。
Stem Cell Rev Rep. 2010 Jun;6(2):143-50. doi: 10.1007/s12015-010-9133-6.
引入在其他机构获得的人类多能干细胞系:根据伦理问题调整审查
Cell Stem Cell. 2009 Feb 6;4(2):115-23. doi: 10.1016/j.stem.2009.01.013.
4
Distribution of human embryonic stem cell lines: who, when, and where.人类胚胎干细胞系的分布:何人、何时以及何地。
Cell Stem Cell. 2009 Feb 6;4(2):107-10. doi: 10.1016/j.stem.2009.01.002.
5
New ISSCR guidelines underscore major principles for responsible translational stem cell research.国际干细胞研究学会(ISSCR)的新指南强调了负责任的转化干细胞研究的主要原则。
Cell Stem Cell. 2008 Dec 4;3(6):607-9. doi: 10.1016/j.stem.2008.11.009.
6
How to determine whether existing human embryonic stem cell lines can be used ethically.
Cell Stem Cell. 2008 Sep 11;3(3):238-9. doi: 10.1016/j.stem.2008.08.012.
7
Centralized banks for human embryonic stem cells: a worthwhile challenge.人类胚胎干细胞集中库:一项值得应对的挑战。
Cell Stem Cell. 2008 Apr 10;2(4):307-12. doi: 10.1016/j.stem.2008.03.018.
8
Harmonizing standards and coding for hESC research.协调人胚胎干细胞研究的标准与编码。
Cell Stem Cell. 2008 Mar 6;2(3):201-2. doi: 10.1016/j.stem.2008.02.002.
9
Stem cell science: current ethical and policy issues.干细胞科学:当前的伦理与政策问题
Clin Pharmacol Ther. 2007 Sep;82(3):330-3. doi: 10.1038/sj.clpt.6100295. Epub 2007 Jul 18.
10
Legal pathways for cross-border research: building a legal platform for biomedical academia.跨境研究的法律途径:为生物医学学术界构建一个法律平台。
Eur J Hum Genet. 2007 May;15(5):522-4. doi: 10.1038/sj.ejhg.5201792. Epub 2007 Feb 28.